respiratory
COPD

ICS use linked to lung infections


Inhaled corticosteroid use is associated with an increased risk of non-tuberculous mycobacterial pulmonary disease in older patients with obstructive lung disease. The Canadian study of more than 417,000 patients aged ≥66 years with asthma, COPD or asthma-COPD overlap syndrome (ACOS) found the association was significant for COPD and ACOS patients but not for those with ...

Already a member?

Enter your email to keep reading.


OR